Research
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b2266 (Published 24 June 2009) Cite this as: BMJ 2009;338:b2266
Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Appendix 1: Explanation of model fitting strategy
- Data Supplement - Appendix 2: Predictors of hip bone mineral density in final mixed model
- Data Supplement - Appendix 3: Estimating variation in treatment effects using summary data
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Appendix 1: Explanation of model fitting strategy
- Data Supplement - Appendix 2: Predictors of hip bone mineral density in final mixed model
- Data Supplement - Appendix 3: Estimating variation in treatment effects using summary data
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Appendix 1: Explanation of model fitting strategy
- Data Supplement - Appendix 2: Predictors of hip bone mineral density in final mixed model
- Data Supplement - Appendix 3: Estimating variation in treatment effects using summary data
Related articles
- Editorial Published: 24 June 2009; BMJ 338 doi:10.1136/bmj.b1276
- Education And Debate Published: 21 September 1996; BMJ 313 doi:10.1136/bmj.313.7059.744
- Analysis Published: 14 February 2008; BMJ 336 doi:10.1136/bmj.39476.623611.25
See more
- Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisBMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188
- NHS to fund large trial of pre-exposure prophylaxis for HIV preventionBMJ December 05, 2016, 355 i6537; DOI: https://doi.org/10.1136/bmj.i6537
- Bill to boost medical research funding and speed drug approval passes US houseBMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498
- Alpha blockers for treatment of ureteric stones: systematic review and meta-analysisBMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112
- Sixty seconds on . . . solanezumabBMJ November 29, 2016, 355 i6389; DOI: https://doi.org/10.1136/bmj.i6389
Cited by...
- To repeat or not to repeat? Measuring bone mineral density during anti-resorptive therapy or a drug holiday
- Subsequent hip fractures in patients identified by a Fracture Liaison Service (FLS) in England and Wales - linkage of the national FLS and Hip Fracture databases
- Bisphosphonates: forever or 5 years and stop?
- Dual-Energy X-Ray Absorptiometry: Overused, Neglected, or Just Misunderstood?
- Is Monitoring BMD Necessary in Patients Who Take Bisphosphonates?
- Monitoring BMD After Starting Bisphosphonate Treatment
- Monitoring bone mineral density during antiresorptive treatment for osteoporosis